D
ESPITE a slow preoperative growth, many oligodendrogliomas recur relatively soon after operation2 '5'7'9'I~ Whether or not this type of glioma is sensitive to roentgen-ray therapy is unclear from the present literature. Some observers 2,6,s believe they are resistant or the value of radiation therapy is uncertain.* Bloor et al. 1 reported that of 5 patients with oligodendrogliomas given irradiation only at the time of recurrence, all obtained remissions. The remissions averaged ~1 months, 4 of these patients being still alive at the time of the report. This present report reviews the results of treatment of 15 patients with oligodendroglioma in an effort to evaluate whether or not roentgen-ray therapy was useful.
Material
The pertinent facts concerning this series of 15 patients with verified intracranial oligodendrogliomas are presented in Table 1 . They conform, in general, to other reported series: the frontal lobes were the predominant location (10 of the 15 cases) ; there were intraventricular tumors and 3 neoplasms of the parietal lobe; the preoperative duration of symptoms averaged 33.7 months with a range of 5 weeks to 1~ years; 7 of the tumors had sufficient calcification to be identified preoperatively. There was no postoperative mortality and none of the patients was reoperated upon. Five patients of the series were given immediate postoperative irradia: tion, and 4 of these were given second courses of irradiation when recurrence of the tumor was identified. Four other patients were given irradiation for the first time only when symptoms of recurrent tumor were clearly established. Six patients received no roentgen-ray treatment at any time. Radiation Received for publication March 5, 1964. therapy was administered in a uniform manner to all patients. The factors employed were ~50 kV., 15 mA., target-skin distance 50 cm. and Thoracus filter (h.v.1. ~.9 ram. Cu). Three ports were generally used. Two opposing lateral and one frontal or occipital on the side of the lesion. In a few instances a fourth port, rostrally, was used. Treatment was delivered starting with 100 r in air and gradually increased to about 300 r in air daily to one of the ports in rotation 5 days weekly.
Results
The 6 patients who received no irradiation had an average preoperative duration of symptoms just over 6 months (range * to 1, months). Four of these patients have died:
died from recurrence of tumor 16 to ~4 months postoperatively; 1 (M.F.) died 8 months after operation because of debility, indirectly the result of extensive neurological damage from bilateral invasion of the frontal lobes; 1 (R.M.) died as the result of intercurrent diabetes and hypertensive cardiovascular disease and possible recurrent tumor 10 months after operation. Two of this group are alive and functioning normally, 1 more than 30 months and the other more than 60 months after operation.
Five patients were given immediate postoperative roentgen-ray therapy. One (E.A.) after administration of 3,000 r to the site of tumor through 3 ports, had a rapid onset of hemiplegia and then progressive debility ending in death 5 months postoperatively. Autopsy revealed no evidence of tumor in his brain but there were extensive areas of cerebral atrophy and gliosis. He was judged to have had an unfortunate reaction to irradiation. The other 4 patients all received full courses of deep roentgen-ray therapy in tumor doses ranging from 4,750 to 6,500 r, and 57 
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Remarks all had evidences of recurrence of tumor at ~4, 41, 68 and ~0 months (average 38 months). They were all then given second courses of irradiation ranging from tumor doses of ~,000 to 3,580 r and remission of symptoms resulted for an additional ~4, ~4, 54 and 48 months respectively, increasing the average total survival time in these 4 cases to 76 months (48, 65, 1~ and 68 months).
Four patients were given irradiation for the first time when recurrence of tumor manifested itself postoperatively. By chance, at least as retrospectively appraised, these 4 patients had longer preoperative duration of symptoms (1, 5, 6, and 9 years) than did the other groups in this series. Nevertheless, these patients gave evidence of recurrence of tumor, on the average ~9 months (13, ~4, 88 and 40 months) after operation. The evidence of recurrence of tumor was the appearance of recurrent hemiparesis in ~ instances and symptoms of increasing intracranial pressure in all instances. Each patient was then given irradiation therapy in comparatively moderate dosages, ranging from ~,500 to 4,6~0 r, and prompt and unequivocal remissions were produced in all symptoms. Three patients returned to fully useful lives and the fourth, the oldest of this group, has not had sufficient improvement of her hemiparesis to resume her full household duties. These 4 patients are all still alive now ~1, 48, 66 and 68 months following operation.
Comment
The conclusion from a review of this material is that oligodendrogliomas are sensitive to roentgen-ray treatment. The evidence consists of the fact that irradiation alone in-
